Evidence map›Paper›PMID 39997614›Full record

ReviewNon-coding RNA2025

The Role of microRNA in the Regulation of Differentiation and the Functionality of Osteoblasts, Osteoclasts, and Their Precursors in Osteoporosis.

Bulat I Yalaev, Elena I Kaletnik, Yulia S Karpova, Zhanna E Belaya, Ildar R Minniakhmetov, Natalia G Mokrysheva, Rita I Khusainova

Abstract readReview
In one paragraph

Review in Non-coding RNA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bulat I YalaevEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0003-4337-1736
Elena I KaletnikEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0002-6013-1462
Yulia S KarpovaEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0001-6688-7271
Zhanna E BelayaEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0002-6674-6441
Ildar R MinniakhmetovEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0002-7045-8215
Natalia G MokryshevaEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.
Rita I KhusainovaEndocrinology Research Centre, Dmitry Ulyanov Street, 11, 117292 Moscow, Russia.ORCID 0000-0002-8643-850X

Funding

Russian Science Foundation 24-75-00054
6 · The paper itself

Abstract

Osteoporosis is a complex disease that is affected by a variety of factors, including genetic and epigenetic influences. While DNA markers for osteoporosis have been identified, they do not fully explain the hereditary basis of the disease. Epigenetic factors, such as small microRNAs (miRNAs), may provide a missing link in understanding the molecular mechanisms underlying osteoporosis. miRNAs are a class of non-coding RNAs that play a role in the epigenetic regulation of gene expression. They are known to be involved in various biological processes, including bone formation and remodelling. Differential expression of miRNAs has been linked to the pathological decrease in bone mineral density associated with osteoporosis. It has been shown that an abnormal miRNA expression pattern leads to a decrease in osteoblast activity and an increase in osteoclast activity. Further research into the role of miRNAs in osteoporosis may help to better understand this disease and identify potential therapeutic targets for treatment. Based on these assumptions, the study of miRNA expression patterns in osteoblasts, osteoclasts, and their precursors under normal and osteoporotic conditions is a rapidly growing field of scientific research. Although the results of this research are still incomplete and sometimes contradictory, they require additional scientific analysis to better understand the complex mechanisms involved. The purpose of this paper is to review the current research on miRNAs specifically expressed in osteoblasts and osteoclasts under both normal and pathological conditions. We will also discuss the potential applications of these miRNAs as biomarkers for osteoporosis diagnosis and as targets for osteoporosis treatment.

Indexed as

bonediagnosticsdifferentiationepigeneticsmicroRNAsosteoblastsosteoclastsosteoporosisprecursorsregulationtherapytissue

Identifiers

PMID39997614
PMCPMC11858178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.